Our mechanistic studies of FCHSD2 and Rab7 function in NSCLC cell lines were consistent with clinical databases showing that high levels of FCHSD2 expression and, reciprocally, low levels of Rab7 expression correlate with improved survival rates. This evidence concerns the gene FCHSD2 and non-small cell lung carcinoma.